In a report released today, Gregory Aurand from Noble Financial maintained a Buy rating on ChitogenX (CHNXF - Research Report), with a price...
Noble Financial analyst Gregory Aurand reiterated a Buy rating on ChitogenX (CHNXF - Research Report) today and set a price target of $1.05. The...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.